Related Experiment Videos
Brussels Statement document
M Piccart1, L Cataliotti, M Buchanan
1Department of Chemotherapy, Institut J. Bordet, 1 rue Héger-Bordet, B-1000, Brussels, Belgium. martine.piccart@bordet.be
European Journal of Cancer (Oxford, England : 1990)
|July 4, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study.
ESMO open·2026
Same author
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study.
ESMO open·2025
Same author
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author
Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance.
ESMO open·2025
Same journal
Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.
European journal of cancer (Oxford, England : 1990)·2026
Same journal
Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.
European journal of cancer (Oxford, England : 1990)·2026
Same journal
Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.
European journal of cancer (Oxford, England : 1990)·2026
Same journal
Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.
European journal of cancer (Oxford, England : 1990)·2026
Same journal
Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.
European journal of cancer (Oxford, England : 1990)·2026
Same journal
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).
European journal of cancer (Oxford, England : 1990)·2026